ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 1,797 shares, the number of shares held decreased 0.39% compared to the previous period and now represents 4.43% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 7,389 shares, the number of shares held decreased 0.39% compared to the previous period and now represents 2.39% of the total position.
      109Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 7,593 shares, the number of shares held decreased 0.39% compared to the previous period and now represents 2.15% of the total position.
      24Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 39,516 shares, the number of shares held decreased 0.39% compared to the previous period and now represents 0.97% of the total position.
      6.20K1
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 17,733 shares, the number of shares held decreased 0.39% compared to the previous period and now represents 2.56% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Absci Corporation. by 43,182 shares, the number of shares held decreased 0.39% compared to the previous period and now represents 6.02% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 11,505 shares, the number of shares held decreased 0.39% compared to the previous period and now represents 6.89% of the total position.
      15Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 6,252 shares, the number of shares held decreased 0.39% compared to the previous period and now represents 2.22% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 739 shares, the number of shares held increased 0.13% compared to the previous period and now represents 0.96% of the total position.
      56Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 951 shares, the number of shares held decreased 0.39% compared to the previous period and now represents 4.21% of the total position.
      24Comment
      Report
       
       
       
       

      Most Discussed